What causes elevated prolactin levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Elevated Prolactin Levels

Hyperprolactinemia results from prolactinomas, dopamine-antagonist medications, primary hypothyroidism, chronic kidney disease, hepatic disease, or pituitary stalk compression—with prolactinomas being the most common pathological cause and medications being one of the most frequent overall causes. 1

Pathological Causes

Prolactinomas

  • Prolactinomas are the most common pathological cause of chronic hyperprolactinemia, with prolactin levels typically exceeding 4,000 mU/L (approximately 200 ng/mL) in children and adolescents. 1
  • Prolactin levels directly correlate with tumor size—values >250 ng/mL are highly suggestive of prolactinomas and virtually exclude nonfunctioning pituitary adenomas. 2
  • However, up to 25% of patients with microprolactinomas or cystic macroprolactinomas may present with prolactin <100 ng/mL, representing an important diagnostic pitfall. 2
  • Approximately 93% of pediatric prolactinomas present after age 12, with a 3-4.5 times higher prevalence in females. 3

Pituitary Stalk Compression

  • Mass lesions compressing the pituitary stalk interrupt the inhibitory dopaminergic tone on lactotroph cells, resulting in elevated prolactin levels (the "stalk effect"). 1
  • Most patients with nonfunctioning pituitary adenomas causing stalk compression present with prolactin levels <100 ng/mL. 2
  • A critical pitfall is the "hook effect"—falsely low prolactin levels in patients with large pituitary adenomas (≥3 cm) due to immunoassay saturation, occurring in approximately 5% of macroprolactinomas. 3, 2
  • The hook effect should be excluded by performing serial serum dilutions (1:100) for prolactin measurement whenever large pituitary masses have disproportionately low prolactin levels. 1, 2

Medication-Induced Hyperprolactinemia

Medications are one of the most common causes of hyperprolactinemia, acting through direct prolactin stimulation or dopamine antagonism. 1

Antipsychotic Agents

  • Typical antipsychotics and risperidone (an atypical agent) are the most frequent medication culprits causing hyperprolactinemia. 4, 5
  • Other atypical antipsychotics like olanzapine and clozapine infrequently cause hyperprolactinemia. 5
  • Women are more sensitive than men to the hyperprolactinemic effects of antipsychotics. 5

Other Medications

  • Antidepressants with serotonergic activity (SSRIs, MAO inhibitors, some tricyclics) can elevate prolactin. 5
  • Prokinetic agents (like prochlorperazine/Stemetil) cause hyperprolactinemia through dopamine antagonism. 1
  • Additional culprits include antihypertensive agents, H2-receptor antagonists, opiates, estrogens, anti-androgens, and anticonvulsants. 4, 5

Endocrine and Systemic Causes

Primary Hypothyroidism

  • Primary hypothyroidism causes hyperprolactinemia in 43% of women and 40% of men with frank disease, and in 36% of women and 32% of men with subclinical hypothyroidism. 1
  • The mechanism involves compensatory hypersecretion of thyrotropin-releasing hormone (TRH), which stimulates prolactin release. 1
  • Hypothyroidism may produce pituitary hyperplasia that mimics a prolactinoma on imaging. 1
  • While prolactin elevation is generally modest (<100 ng/mL), rare cases with severe hypothyroidism have reached 323 ng/mL, particularly when combined with macroprolactinemia. 6

Chronic Kidney Disease

  • Hyperprolactinemia occurs in 30-65% of adult patients with chronic kidney disease due to both increased prolactin secretion and reduced renal clearance. 1
  • Prolactin values can exceed 250 ng/mL in chronic renal failure, potentially mimicking prolactinomas. 2

Severe Liver Disease

  • Hepatic disease is associated with hyperprolactinemia in adults, though the mechanism is less well-defined than renal disease. 1

Other Causes

Macroprolactinemia

  • Macroprolactinemia accounts for 10-40% of all hyperprolactinemia cases and represents the third most frequent cause after medications and prolactinomas. 7, 2
  • Macroprolactin has low biological activity, yet up to 40% of macroprolactinemic patients present with hypogonadism symptoms, infertility, or galactorrhea. 2
  • Approximately 20% of patients with macroprolactinemia have coexisting pituitary adenomas, making imaging still necessary in symptomatic cases. 7

Physiological and Stress-Related

  • Pregnancy is a physiologic cause that must be excluded in women of reproductive age. 7
  • Stress can elevate prolactin levels up to five times the upper limit of normal, necessitating serial measurements for modestly elevated levels. 1, 7

Rare Causes

  • Intracranial hypotension, tetrahydrobiopterin deficiency, and chest wall lesions can cause hyperprolactinemia. 1

Diagnostic Algorithm

When evaluating hyperprolactinemia, the Endocrine Society recommends this systematic approach:

  1. Exclude pregnancy in all women of reproductive age. 7
  2. Review all medications for dopamine antagonists or serotonergic agents. 7
  3. Measure TSH to exclude primary hypothyroidism. 7
  4. Assess renal function (creatinine/eGFR) and liver function tests. 7
  5. Test for macroprolactin using polyethylene glycol (PEG) precipitation when prolactin is mildly or incidentally elevated, especially in asymptomatic patients. 7
  6. Obtain pituitary MRI after excluding secondary causes to evaluate for prolactinomas or other masses. 7
  7. Perform serial dilutions if large pituitary masses have disproportionately low prolactin to exclude the hook effect. 7

References

Guideline

Etiology of Hyperprolactinemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Hyperprolactinemia in Children and Adolescents

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Drugs and prolactin.

Pituitary, 2008

Research

Pharmacological causes of hyperprolactinemia.

Therapeutics and clinical risk management, 2007

Guideline

Management of Hyperprolactinemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.